Jefferies Financial Group Research Analysts Increase Earnings Estimates for CME Group Inc. (NASDAQ:CME)

CME Group Inc. (NASDAQ:CMEGet Rating) – Stock analysts at Jefferies Financial Group boosted their Q1 2022 earnings estimates for shares of CME Group in a report released on Monday, April 11th. Jefferies Financial Group analyst D. Fannon now forecasts that the financial services provider will post earnings of $1.98 per share for the quarter, up from their previous forecast of $1.91. Jefferies Financial Group also issued estimates for CME Group’s Q4 2022 earnings at $1.81 EPS.

CME Group (NASDAQ:CMEGet Rating) last released its quarterly earnings data on Wednesday, February 9th. The financial services provider reported $1.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.64 by $0.02. CME Group had a return on equity of 8.93% and a net margin of 56.22%. The business had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same quarter in the prior year, the firm posted $1.39 EPS.

A number of other research analysts have also issued reports on the company. JPMorgan Chase & Co. decreased their target price on CME Group from $202.00 to $201.00 and set a “neutral” rating on the stock in a research report on Thursday, February 10th. Rosenblatt Securities increased their target price on CME Group from $260.00 to $268.00 and gave the company a “neutral” rating in a research report on Tuesday, March 8th. UBS Group decreased their target price on CME Group from $275.00 to $269.00 in a research report on Tuesday, April 5th. Morgan Stanley increased their target price on CME Group from $234.00 to $255.00 and gave the company an “equal weight” rating in a research report on Friday, February 11th. Finally, Raymond James increased their price objective on CME Group from $240.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday, February 10th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $252.08.

Shares of NASDAQ:CME opened at $236.03 on Wednesday. CME Group has a 1 year low of $185.79 and a 1 year high of $256.94. The firm has a market capitalization of $84.83 billion, a price-to-earnings ratio of 32.29, a price-to-earnings-growth ratio of 3.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. The business’s 50 day moving average price is $239.79 and its 200-day moving average price is $227.37.

Institutional investors have recently made changes to their positions in the stock. CAPROCK Group Inc. boosted its holdings in CME Group by 2.4% during the 1st quarter. CAPROCK Group Inc. now owns 5,224 shares of the financial services provider’s stock valued at $1,243,000 after acquiring an additional 121 shares during the period. NuWave Investment Management LLC purchased a new position in CME Group during the 1st quarter valued at about $548,000. Bromfield Sneider Wealth Advisors purchased a new position in CME Group during the 1st quarter valued at about $26,000. Dynamic Advisor Solutions LLC boosted its holdings in CME Group by 33.0% during the 1st quarter. Dynamic Advisor Solutions LLC now owns 2,810 shares of the financial services provider’s stock valued at $668,000 after acquiring an additional 698 shares during the period. Finally, Veriti Management LLC boosted its holdings in CME Group by 11.8% during the 1st quarter. Veriti Management LLC now owns 5,953 shares of the financial services provider’s stock valued at $1,416,000 after acquiring an additional 626 shares during the period. Institutional investors own 84.58% of the company’s stock.

In related news, insider Kevin Kometer sold 13,500 shares of the firm’s stock in a transaction dated Thursday, February 10th. The stock was sold at an average price of $244.04, for a total transaction of $3,294,540.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Sunil Cutinho sold 4,900 shares of the firm’s stock in a transaction dated Monday, February 14th. The stock was sold at an average price of $237.96, for a total value of $1,166,004.00. The disclosure for this sale can be found here. Insiders sold a total of 32,650 shares of company stock valued at $7,814,564 over the last ninety days. Corporate insiders own 0.30% of the company’s stock.

The business also recently announced a quarterly dividend, which was paid on Friday, March 25th. Shareholders of record on Thursday, March 10th were paid a $1.00 dividend. The ex-dividend date of this dividend was Wednesday, March 9th. This is an increase from CME Group’s previous quarterly dividend of $0.90. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.69%. CME Group’s dividend payout ratio (DPR) is 54.72%.

CME Group Company Profile (Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

See Also

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.